Correction: An Anti-β-Amyloid vaccine for treating cognitive deficits in a mouse model of down syndrome

• Published in: PloS one Vol. 20; no. 5; p. e0324280
• Main Authors: Belichenko, Pavel V., Madani, Rime, Rey-Bellet, Lorianne, Pihlgren, Maria, Becker, Ann, Plassard, Adeline, Vuillermot, Stephanie, Giriens, Valérie, Nosheny, Rachel L., Kleschevnikov, Alexander M., Valletta, Janice S., Bengtsson, Sara K. S., Linke, Gordon R., Maloney, Michael T., Hickman, David T., Reis, Pedro, Granet, Anne, Mlaki, Dorin, Lopez-Deber, Maria Pilar, Do, Long, Singhal, Nishant, Masliah, Eliezer, Pearn, Matthew L., Pfeifer, Andrea, Muhs, Andreas, Mobley, William C.
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 2025; Public Library of Science (PLoS)
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0324280

(B) Quantification of GFAP immunoreactive optical density revealed no difference between treatment groups in either layers II-III motor cortex (left) or superior blade of dentate gyrus (right). IL-1 and IL-6 decreased following immunization in the plasma of Ts65Dn mice treated with the DS-01 vaccine (One-way ANOVA, Bonferroni’s multiple comparison test **—p < 0.01 and *—p < 0.05 respectively). The authors note that they were unable to locate the complete set of individual-level data underlying Fig 1, but they have provided the available raw PCR data underlying Fig 1A (S4 File).